> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Invesco Reports 5.4% Integra LifeSciences Stake — Adviser Clients Own The Shares
- URL: https://www.bullished.co/invesco-reports-5-4-integra-lifesciences-stake-adviser-clients-own-the-shares-e99fcfe8/
- Published: 2026-11-10T21:11:17.000Z
- Updated: 2026-11-10T21:11:17.000Z
- Description: The passive position covered 4,164,366 shares, with no individual client holding more than 5% economic ownership.
- Author: Matteo Parrino
- Tags: SEC Filings, IART, Industry: Healthcare

Invesco reported a [5.4% stake](https://www.sec.gov/Archives/edgar/data/0000914208/000091420826000418/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) in [Integra LifeSciences](https://www.bullished.co/tag/iart/), which makes medical devices, in a passive ownership disclosure filed Tuesday. The 4,164,366 shares were held by investment-adviser clients, with ownership attributed to Invesco as the advisers' parent holding company.

## Clients Keep The Economic Rights

The position was measured as of September 30\. Invesco's reported beneficial ownership — the basis used to attribute the stake to the parent — differs from an individual client's economic interest: no client held more than 5% economic ownership.

The clients have the rights to dividends and money from share sales. The disclosure named Invesco Advisers and Invesco Capital Management as the investment advisers and reported sole voting authority over 4,164,293 shares, with no shared voting authority.

Invesco certified that the shares were [held through ordinary business activity](https://www.sec.gov/Archives/edgar/data/0000914208/000091420826000418/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co), rather than for an effort to change or influence Integra's control.

## Profit, A Neutral Rating And A Gain

Integra reported third-quarter revenue of $411.2 million and earnings of $14.9 million, producing a 3.61% profit margin. UBS maintained its Neutral rating on October 27 and lowered its price target.

IART shares soared 7.08% to $14.37 at the November 9 close. Integra's market capitalization was $1.1 billion as of Tuesday at 4:09 p.m. ET; the earlier share-price gain provides context for the ownership report, rather than a reaction to it.

Integra supplies products for neurosurgery, wound care and tissue repair, including products that repair the protective membrane around the brain, fill bone voids and repair nerves and tendons. Some use bovine or porcine tissue; products containing bovine-derived material accounted for 26% of revenue in 2025.

The reported 5.4% stake represents shares held across adviser clients, whose dividend and sale-proceeds rights remain their own.

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — Invesco Ltd. re: Integra LifeSciences Holdings Corp (IART)](https://www.sec.gov/Archives/edgar/data/0000914208/000091420826000418/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR
- [Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo Finance](https://ca.finance.yahoo.com/quote/IART/?ref=bullished.co) — Yahoo Finance
- [Integra LifeSciences (IART) Stock Could Be A Bargain Based On Cash Flow](https://sg.finance.yahoo.com/news/integra-lifesciences-iart-stock-could-221641566.html?ref=bullished.co) — Yahoo Finance

### More on Integra LifeSciences

- [Integra's Tissue Reconstruction Unit Clears Goodwill Test With 11.3% To Spare, A Year After $511.4 Million Write-Off](https://www.bullished.co/integras-tissue-reconstruction-unit-clears-goodwill-test-with-11-3-to-spare-a-year-after-8581975a/)
- [Integra CEO Expects To 'Lose Some Business' In Neurosurgery As Mayfield Clamp Supply Runs Short Into 2027](https://www.bullished.co/integra-ceo-expects-to-lose-some-business-in-neurosurgery-as-mayfield-clamp-supply-runs-ced12802/)
- [Integra Posts $14.9 Million Profit Against Year-Ago Loss, With Revenue Up 2.3% To $411.2 Million](https://www.bullished.co/integra-posts-14-9-million-profit-against-year-ago-loss-with-revenue-up-2-3-to-411-2-f6cdb83e/)

[All Integra LifeSciences (IART) coverage →](https://www.bullished.co/tag/iart/)